Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dan Jinga"'
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Phosphorus Research Bulletin. 10:708-713
Publikováno v:
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 27(1)
Epirubicin is a cytotoxic drug, widely used in patients with breast cancer, but its application is limited by its cardiotoxicity. Assessment of left ventricular (LV) ejection fraction (EF) is performed to demonstrate cardiac dysfunction. Because norm
Autor:
Dan Jinga, Oana Aurelia Enescu, Stefania L Magda, Maria Florescu, Mircea Cinteza, Dragos Vinereanu
Publikováno v:
Journal of the American College of Cardiology. 55(10)
Autor:
José A. García-Sáenz, Dan Jinga, Manuel Ruiz-Borrego, Serafin Morales, Christoph C. Zielinski, Laura Murillo, Bella Nisenbaum, Miguel Martin, István Láng, Miguel Gil, Semir Beslija, Antonio Antón, Moshe Inbar, Günther G. Steger, Eva Carrasco, Zsuzanna Kahan, Jose Ignacio Chacon, Juan de la Haba, Begoña Bermejo, Ma José Escudero
Publikováno v:
Cancer Research. 75:OT1-1
Background: Endocrine therapy (ET) is the cornerstone treatment for HR–positive, HER2-negative breast cancer (BC) patients. AIs have become the treatment of choice in postmenopausal patients. The high response rates with ET in these patients are pa